Age, the extent of resection (EOR), the size of necrosis, and some molecular markers [including the methylation status of O6-methylguanine-DNA methyltransferase (MGMT) and overexpression of the epidermal growth factor receptor (EGFR)] are all relevant factors accounting for the diversity of GBM outcomes. Here, MGMT is linked to glioblastoma.